ArticleAntiviral research2022

Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.

Hirofumi Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.